Skip to main content

OxyContin Sales Data

Rank 19 Current sales rank, all
U.S. Pharmaceuticals.

Last updated: February 2014 (updated quarterly).
The following data shows OxyContin U.S. retail sales in Q4 2013 compared to previous quarters.

Date Range Sales Rank Sales ($000) Units (000)
Q4 2013 19 -2.91% -1.87%
Q3 2013 19 (2) -3.01% -3.52%
Q2 2013 17 (2) -4.71% -5.87%
Q1 2013 15 (1) -2.38% -5.47%
Q4 2012 14 (1) -1.69% -0.72%
Q3 2012 13 (2) -0.55% 0.16%
Q2 2012 15 (3) 3.14% 0.16%
Q1 2012 18 (1) -1.05% -2.35%
Q4 2011 17 (2) -2.58% -1.69%
Q3 2011 19 (2) -5.33% -4.69%
Q2 2011 17 2.82% -1.02%
Q1 2011 17 n/a n/a

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Related News

DateArticle
September 2, 2021OxyContin Maker Purdue Pharma Is Dissolved
September 2, 2021Oxycontin Maker Purdue Dissolved, Family to Pay $4.5 Billion in Bankruptcy Settlement
August 19, 2021Family Behind Oxycontin Denies Any Responsibility for Opioid Crisis
March 16, 2021Opioid Maker Purdue Pharma Files Bankruptcy Plan